CD82 and breast carcinoma: Further, to the best of our knowledge, this study is the first to investigate KAI-1 expression using three different techniques i.e. Real time PCR, Western blot and IHC in the patients of breast cancer and confirmed a consistency between the mRNA expression investigated by Real time PCR and protein expression by both Western blot and IHC.